• LAST PRICE
    79.2200
  • TODAY'S CHANGE (%)
    Trending Up0.2000 (0.2531%)
  • Bid / Lots
    79.2100/ 1
  • Ask / Lots
    79.2200/ 4
  • Open / Previous Close
    79.2500 / 79.0200
  • Day Range
    Low 79.0350
    High 80.1800
  • 52 Week Range
    Low 72.8659
    High 89.7400
  • Volume
    2,342,226
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 79.02
TimeVolumeGILD
09:32 ET9685979.24
09:33 ET1601179.27
09:35 ET1525279.15
09:37 ET949379.095
09:39 ET903079.26
09:42 ET837679.37
09:44 ET1896879.38
09:46 ET1680379.35
09:48 ET2650679.25
09:50 ET1240979.39
09:51 ET564279.31
09:53 ET3947079.31
09:55 ET1772579.45
09:57 ET2215579.52
10:00 ET1264679.595
10:02 ET1730379.47
10:04 ET1716879.485
10:06 ET1499779.55
10:08 ET2604179.66
10:09 ET5776179.8175
10:11 ET6561779.885
10:13 ET4660679.845
10:15 ET20540179.98
10:18 ET1799079.98
10:20 ET2057779.995
10:22 ET2676979.995
10:24 ET3052879.99
10:26 ET4216180.01
10:27 ET2130980.07
10:29 ET2991480.13
10:31 ET1888080.04
10:33 ET1431180.045
10:36 ET2693280.06
10:38 ET1916780.045
10:40 ET1155280.015
10:42 ET1374280.02
10:44 ET1223280.02
10:45 ET1676780.01
10:47 ET1630179.985
10:49 ET1600179.92
10:51 ET930979.77
10:54 ET2260579.72
10:56 ET1197579.7
10:58 ET1288679.71
11:00 ET708779.745
11:02 ET2022179.7
11:03 ET1256379.805
11:05 ET1332979.785
11:07 ET1222279.8
11:09 ET1103079.73
11:12 ET1144379.72
11:14 ET1697779.77
11:16 ET1343679.77
11:18 ET1418879.78
11:20 ET1560979.7098
11:21 ET1611779.72
11:23 ET2234179.708
11:25 ET1284879.72
11:27 ET1756179.8
11:30 ET472779.74
11:32 ET1807679.7
11:34 ET2741179.6
11:36 ET2246679.645
11:38 ET1438679.585
11:39 ET1699479.49
11:41 ET1859379.48
11:43 ET1041779.475
11:45 ET803379.47
11:48 ET1225779.53
11:50 ET696779.59
11:52 ET659479.57
11:54 ET1057279.5611
11:56 ET1954079.545
11:57 ET2292479.565
11:59 ET2881679.515
12:01 ET933979.48
12:03 ET495179.43
12:06 ET675079.47
12:08 ET546679.505
12:10 ET686579.545
12:12 ET1709679.5415
12:14 ET409079.45
12:15 ET571679.42
12:17 ET1884579.405
12:19 ET379079.37
12:21 ET359579.335
12:24 ET904479.325
12:26 ET701879.33
12:28 ET761179.33
12:30 ET778879.35
12:32 ET1441779.395
12:33 ET802579.36
12:35 ET607779.365
12:37 ET993279.4
12:39 ET3839379.36
12:42 ET637779.34
12:44 ET496079.295
12:46 ET846679.23
12:48 ET3429179.22
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGILD
Gilead Sciences Inc
98.5B
17.0x
-13.86%
United StatesAMGN
Amgen Inc
145.0B
19.2x
+1.96%
United StatesBMY
Bristol-Myers Squibb Co
102.2B
12.6x
+4.53%
United StatesGSK
GSK plc
74.8B
9.7x
+9.56%
United StatesHLN
HALEON PLC
37.7B
24.2x
---
United StatesVTRS
Viatris Inc
11.5B
6.4x
+2.13%
As of 2023-12-06

Company Information

Gilead Sciences, Inc. is a biopharmaceutical company. The Company is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company offers products in HIV, Onocolgy, Liver Disease, Vekulaery, and Other. Under HIV, it offers Biktarvy, Complera/Eviplera, Genvoya, Odefsey, Stribild, and Truvada. Its Veklury (remdesivir) is a nucleotide analog RNA polymerase inhibitor indicated for the treatment of coronavirus disease 2019 (COVID-19). Under oncology it offers cell therapy containing Tecartus and Yescarta. Under this Liver Disease consists of Chronic hepatitis C virus (HCV) (Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir) and Chronic hepatitis B virus (HBV) / hepatitis delta virus (HDV) (Vemlidy and Viread). The Company's other products include AmBisome and Letairis. It also operates a portfolio of small molecule inhibitors targeting PARP1 for oncology and MK2 for inflammatory diseases.

Contact Information

Headquarters
333 LAKESIDE DRFOSTER CITY, CA, United States 94404
Phone
650-574-3000
Fax
650-578-9264

Executives

Chairman of the Board, Chief Executive Officer
Daniel O'Day
Chief Financial Officer
Andrew Dickinson
Executive Vice President - Corporate Affairs, General Counsel, Corporate Secretary
Deborah Telman
Executive Vice President - Pharmaceutical Development and Manufacturing
Stacey Ma
Executive Vice President - Research
Flavius Martin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$98.5B
Revenue (TTM)
$27.4B
Shares Outstanding
1.2B
Dividend Yield
3.79%
Annual Dividend Rate
3.0000 USD
Ex-Dividend Date
12-14-23
Pay Date
12-28-23
Beta
0.24
EPS
$4.66
Book Value
$17.03
P/E Ratio
17.0x
Price/Sales (TTM)
3.6
Price/Cash Flow (TTM)
11.7x
Operating Margin
30.16%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.